Bioxytran Inc (BIXT)
0.1253
0.00 (0.00%)
USD |
OTCM |
May 17, 12:12
Bioxytran Cash from Financing (TTM): 0.5659M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 0.5659M |
December 31, 2023 | 0.5504M |
September 30, 2023 | 0.5854M |
June 30, 2023 | 0.795M |
March 31, 2023 | 0.73M |
December 31, 2022 | 2.061M |
September 30, 2022 | 1.981M |
June 30, 2022 | 1.381M |
March 31, 2022 | 2.696M |
December 31, 2021 | 1.765M |
September 30, 2021 | 2.707M |
June 30, 2021 | 2.715M |
March 31, 2021 | 1.40M |
December 31, 2020 | 0.9811M |
September 30, 2020 | 0.3612M |
June 30, 2020 | 0.3731M |
March 31, 2020 | 0.3731M |
December 31, 2019 | 0.5643M |
September 30, 2019 | 0.4645M |
June 30, 2019 | 0.4445M |
March 31, 2019 | 0.4445M |
December 31, 2018 | 0.2222M |
September 30, 2018 | 0.0227M |
June 30, 2018 | 0.0224M |
March 31, 2018 | 0.0227M |
Date | Value |
---|---|
December 31, 2017 | 0.0227M |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.0003M |
March 31, 2017 | 0.025M |
December 31, 2016 | 0.05M |
September 30, 2016 | 0.055M |
June 30, 2016 | 0.0443M |
March 31, 2016 | 0.025M |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.0028M |
June 30, 2015 | 0.0135M |
March 31, 2015 | 0.0078M |
December 31, 2014 | 0.0018M |
September 30, 2014 | 0.0016M |
June 30, 2014 | 0.0037M |
March 31, 2014 | 0.0791M |
December 31, 2013 | 0.0932M |
September 30, 2013 | 0.0971M |
June 30, 2013 | 0.1237M |
March 31, 2013 | 0.0513M |
December 31, 2012 | 0.0548M |
September 30, 2012 | 0.1945M |
June 30, 2012 | 0.1587M |
March 31, 2012 | 0.4304M |
December 31, 2011 | 0.5405M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.3612M
Minimum
Sep 2020
2.715M
Maximum
Jun 2021
1.175M
Average
0.7625M
Median
Cash from Financing (TTM) Benchmarks
Shuttle Pharmaceuticals Holdings Inc | -0.5137M |
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 14.71M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.68M |